All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @r0rycity on TikTok · 42s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @r0rycity's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00This is why I switched from Testo Gel to injections.
  2. 0:04I think I switched to injections after a year and a half roughly of gel.
  3. 0:08I found after eight to nine months of Testo Gel, nothing was happening.
  4. 0:12Then I got my blood test done and my testosterone levels were really low.
  5. 0:16So I switched to Nabida.
  6. 0:17Nabida is an injection you take once every 12 to 14 weeks.
  7. 0:21I know there's also Sustininen which you inject yourself.
  8. 0:24Sometimes your skin just starts absorbing the gel a little less.
  9. 0:28I think starting on the gel is really good and a lot more accessible.
  10. 0:32If you notice you're getting to a point where you're not
  11. 0:34progressing as much as you want to in your transition then switching to an injection is really good
  12. 0:38because it just goes right into you, right into your body.

Rory's testosterone gel to injection switch, fact-checked

Rory

TikTok creator

32.5K viewsWatch on TikTok

Quick answer

Transdermal testosterone gel shows clinically significant inter-individual absorption variability, and poor therapeutic response despite adequate dosing is a recognized phenomenon documented in endocrinology literature. Nebido (testosterone undecanoate 1000mg/4mL) is a licensed long-acting injectable with a 10-to-14-week maintenance interval, commonly used in both hypogonadism and gender-affirming hormone therapy when transdermal routes are inadequate. Switching delivery routes requires clinical oversight including baseline and follow-up serum testosterone measurement to verify therapeutic range attainment.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Rory's testosterone gel to injection switch, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Rory's testosterone gel to injection switch, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Rory's testosterone gel to injection switch, fact-checked" from Rory. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Transdermal testosterone gel shows clinically significant inter-individual absorption variability, and poor therapeutic response despite adequate dosing is a recognized phenomenon documented in endocrinology literature.

The reason this review is not generic is the source wording and the canonical claim label "trt let s talk about my switch from testogel to injections." In this clip, the useful excerpt is: "This is why I switched from Testo Gel to injections." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Nebido (testosterone undecanoate) has a licensed 10-to-14-week maintenance dosing interval.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Transdermal testosterone gel shows clinically significant inter-individual absorption variability, and poor therapeutic response despite adequate dosing is a recognized phenomenon documented in endocrinology literature.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Transdermal testosterone gel shows clinically significant inter-individual absorption variability, and poor therapeutic response despite adequate dosing is a recognized phenomenon documented in endocrinology literature. Nebido (testosterone undecanoate 1000mg/4mL) is a licensed long-acting injectable with a 10-to-14-week maintenance interval, commonly used in both hypogonadism and gender-affirming hormone therapy when transdermal routes are inadequate. Switching delivery routes requires clinical oversight including baseline and follow-up serum testosterone measurement to verify therapeutic range attainment.
  • Transdermal testosterone gel absorption varies significantly between individuals. Bhasin et al. (2018) found some patients fail to reach therapeutic serum levels even at standard doses.
  • Nebido (testosterone undecanoate) has a licensed 10-to-14-week maintenance dosing interval. Its long duration is convenient but means dose corrections take weeks to take effect.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Transdermal testosterone gel absorption varies significantly between individuals. Bhasin et al. (2018) found some patients fail to reach therapeutic serum levels even at standard doses.
  • Nebido (testosterone undecanoate) has a licensed 10-to-14-week maintenance dosing interval. Its long duration is convenient but means dose corrections take weeks to take effect.
  • Blood test timing relative to gel application dramatically affects results. Handelsman (2019, Endocrine Reviews) noted that mistimed draws can misrepresent actual average testosterone exposure.
  • The creator confirmed low levels via blood work before switching, which is the correct clinical approach. Switching based on symptoms alone without testing is not recommended.
  • Sustanon and Nebido are both injectable testosterone options with different ester compositions and dosing schedules. The choice between them depends on clinical factors, not just administration preference.
  • Gel non-response after initial progress is a recognized clinical phenomenon, not an indication that testosterone therapy is not working as a category.
  • Any switch in testosterone delivery route should be managed by a prescribing clinician, including baseline measurement and a monitoring plan for the new formulation.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @r0rycity actually say?

@r0rycity described switching from Testogel to a long-acting injectable called Nebido after roughly 18 months on the gel, saying that after eight to nine months "nothing was happening" and blood tests confirmed low testosterone levels. They also named Sustanon as a self-injectable alternative and suggested that "sometimes your skin just starts absorbing the gel a little less." Their core argument: gel is a good starting point, but injections are more reliable if you plateau.

This is a personal experience video, not medical advice, and they frame it that way. That matters. But 32,000 people watched it, and some of the claims deserve a closer look regardless of intent.

Does the science back this up?

Mostly, yes. Transdermal testosterone absorption variability is well-documented, and poor responders are a real clinical phenomenon. The claim that injections deliver testosterone more reliably is supported by pharmacokinetic data.

Gel absorption is genuinely inconsistent. A 2018 study by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism found that transdermal testosterone produces highly variable serum levels across individuals, with some patients failing to reach therapeutic thresholds even at standard doses. Skin thickness, application site, sweating, and washing habits all affect how much actually gets absorbed. So "your skin just starts absorbing the gel a little less" is an oversimplification, but it points at a real mechanism. The more precise explanation is that absorption efficiency varies based on multiple factors and may not be consistent over time.

Nebido (testosterone undecanoate) does have a 10-to-14-week dosing interval, which matches what they said. A 2021 review by Saad et al. in Andrology confirmed its pharmacokinetic profile produces more stable trough levels compared to shorter-acting injectables in many patients.

What did they get wrong (or right)?

The medication name is wrong. They call it "Nabida," but the correct name is Nebido. This is a minor error, likely just a pronunciation issue, but worth flagging because medication names matter when people go searching for information.

They also say Sustanon is something "you inject yourself," implying Nebido is not self-injectable. In practice, Nebido is typically administered by a clinician because of the volume and viscosity of the injection, but Sustanon can also be clinic-administered. The distinction is more about formulation and dosing schedule than a hard rule about who does the injecting. That framing could mislead someone into thinking they have no self-administration option with any long-acting testosterone.

On the positive side, their core advice, get blood work done before switching, is genuinely good. Too many people adjust their own hormone regimens based on how they feel without checking levels. The fact that they confirmed low testosterone via blood test before changing protocols is the right approach, and worth crediting plainly.

What should you actually know?

If you are on testosterone gel and feel like it stopped working, the first step is blood work, not a switch. Poor absorption is one possible explanation, but inconsistent application, timing of the blood draw relative to application, and other factors can produce misleading results. A 2019 study by Handelsman in Endocrine Reviews noted that serum testosterone measured too soon or too late after gel application can dramatically misrepresent average exposure.

Nebido is a real, licensed injectable testosterone used in both hypogonadism treatment and gender-affirming hormone therapy. Its long interval is convenient but also means corrections take weeks if something goes wrong with your dose. It is not universally superior to gel, and it is not a good fit for everyone.

  • Gel non-response is a documented clinical problem, not a personal failure.
  • Blood test timing relative to your last application window significantly affects results.
  • Switching delivery method should involve a prescribing clinician, not just a TikTok video.
  • Both Nebido and Sustanon are legitimate options with different schedules and administration requirements.

This video is a reasonable personal account. It is not a protocol. If your testosterone levels are not where you want them, talk to the clinician managing your hormone therapy before changing anything.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Rory · TikTok creator

32.5K views on this video

Let’s talk about my switch from Testogel to injections 🏳️‍⚧️ #ftm #transman #trans

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about transdermal testosterone gel absorption varies significantly between individuals. bhasin et?

Transdermal testosterone gel absorption varies significantly between individuals. Bhasin et al. (2018) found some patients fail to reach therapeutic serum levels even at standard doses.

What does the video say about nebido (testosterone undecanoate) has a licensed 10-to-14-week maintenance dosing interval.?

Nebido (testosterone undecanoate) has a licensed 10-to-14-week maintenance dosing interval. Its long duration is convenient but means dose corrections take weeks to take effect.

What does the video say about blood test timing relative to gel application dramatically affects results.?

Blood test timing relative to gel application dramatically affects results. Handelsman (2019, Endocrine Reviews) noted that mistimed draws can misrepresent actual average testosterone exposure.

What does the video say about the creator confirmed low levels via blood work before switching,?

The creator confirmed low levels via blood work before switching, which is the correct clinical approach. Switching based on symptoms alone without testing is not recommended.

What does the video say about sustanon?

Sustanon and Nebido are both injectable testosterone options with different ester compositions and dosing schedules. The choice between them depends on clinical factors, not just administration preference.

What does the video say about gel non-response after initial progress?

Gel non-response after initial progress is a recognized clinical phenomenon, not an indication that testosterone therapy is not working as a category.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Rory, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.